Antibiotic Study Guide

📖 Core Concepts Antibiotic – antimicrobial that targets bacteria; can be bactericidal (kills) or bacteriostatic (halts growth). Spectrum – narrow‑spectrum = hits a limited group of bacteria; broad‑spectrum = hits many species. Major Mechanistic Classes Cell‑wall synthesis inhibitors (β‑lactams: penicillins, cephalosporins) → block peptidoglycan → bacterial lysis. Cell‑membrane disruptors (polymyxins) → increase membrane permeability → leak of contents. Protein‑synthesis inhibitors (macrolides, tetracyclines, aminoglycosides) → bind bacterial ribosome, stop translation. Nucleic‑acid synthesis inhibitors (quinolones, rifamycins, sulfonamides) → impair DNA replication or folate metabolism. Pharmacodynamics – therapeutic effect depends on drug concentration relative to the minimum inhibitory concentration (MIC) and the host’s immune status. Resistance – intrinsic (natural lack of target/poor uptake) vs acquired (mutations, horizontal gene transfer). Key strategies: enzymatic degradation, target modification, efflux pumps, reduced permeability. Stewardship – optimizing antibiotic choice, dose, duration, and route to minimize resistance and adverse effects. --- 📌 Must Remember MIC = lowest concentration that prevents visible growth in vitro. MBC = lowest concentration that kills ≥99.9 % of the inoculum. Empiric therapy = start broad‑spectrum before pathogen ID; definitive therapy = switch to narrow‑spectrum once ID is known. Bacteriostatic agents can antagonize bactericidal drugs (e.g., chloramphenicol ↔ penicillins). β‑lactam + β‑lactamase inhibitor (e.g., clavulanic acid) restores activity against β‑lactamase‑producing strains. Rifampicin induces hepatic enzymes → ↓ oral‑contraceptive effectiveness. Common adverse effect – antibiotic‑associated diarrhea; risk of Clostridioides difficile overgrowth. Key resistance mechanisms – enzymatic degradation, target alteration, efflux, reduced permeability. Stewardship tip – use narrow‑spectrum, correct dose, and shortest effective duration. --- 🔄 Key Processes Choosing Empiric Antibiotic Assess infection site, likely pathogens, patient allergies, local resistance patterns → select broad‑spectrum agent. De‑escalation to Definitive Therapy Receive culture/sensitivity → switch to narrow‑spectrum, adjust dose, discontinue unnecessary agents. Combination Therapy Rationale (a) Prevent resistance → use two mechanisms. (b) Broaden spectrum → cover mixed infections. (c) Synergy → β‑lactam + β‑lactamase inhibitor, or aminoglycoside + cell‑wall inhibitor. Resistance Gene Transfer Conjugation (plasmid exchange) → spread of multi‑drug resistance. Transformation / transduction → acquisition of chromosomal or phage‑borne genes. --- 🔍 Key Comparisons Bactericidal vs Bacteriostatic – kills bacteria vs halts growth; bactericidal needed for endocarditis, meningitis, neutropenic patients. Narrow‑spectrum vs Broad‑spectrum – targeted (less collateral damage, lower resistance pressure) vs wide coverage (use when pathogen unknown). β‑lactam vs β‑lactamase inhibitor – antibiotic alone can be inactivated; inhibitor protects β‑lactam from degradation. Empiric vs Definitive Therapy – initial guess vs evidence‑based selection. Synthetic vs Natural Antibiotics – fully chemical synthesis (e.g., sulfonamides) vs derived from microorganisms (e.g., penicillins). --- ⚠️ Common Misunderstandings “Antibiotics work on viruses.” – False; antivirals are a separate drug class. “All antibiotics cause the same side effects.” – Side‑effect profiles vary (e.g., nephrotoxicity with aminoglycosides, photodermatitis with tetracyclines). “Probiotics cure antibiotic‑associated diarrhea.” – They reduce risk; they do not replace treatment for C. difficile. “Antibiotic cycling prevents resistance.” – Recent data show cycling is ineffective; proper stewardship is key. “Oral contraceptives are always safe with antibiotics.” – Rifampicin (and some others) can reduce hormone levels. --- 🧠 Mental Models / Intuition “Lock‑and‑Key” – Match drug class (key) to bacterial target (lock); if lock is altered (resistance), key no longer works. “Concentration > MIC = Success” – Visualize a bar graph: drug level must sit above the MIC line for the dosing interval. “Broad → Narrow” – Think of a funnel: start wide (empiric) then narrow as you gather data. --- 🚩 Exceptions & Edge Cases β‑lactamase inhibitors only protect β‑lactams against certain β‑lactamases; not effective against all (e.g., metallo‑β‑lactamases). Sulfonamides act as folate antagonists, not true nucleic‑acid synthesis inhibitors; they are technically antimetabolites. Rifampicin induces hepatic enzymes → may lower levels of many drugs, not just oral contraceptives. Bacteriostatic drugs may be acceptable in non‑critical infections even when bactericidal agents are traditionally preferred. --- 📍 When to Use Which Severe invasive infections (meningitis, endocarditis, neutropenia) → choose bactericidal, preferably β‑lactam + aminoglycoside. Community‑acquired pneumonia in a healthy adult → macrolide (narrow‑spectrum) or doxycycline if atypicals suspected. Penicillin‑allergic patient → use macrolide or fluoroquinolone (consider cross‑reactivity with cephalosporins). MRSA suspicion → vancomycin or linezolid (cell‑wall synthesis inhibitor vs protein synthesis). Renal impairment → dose‑adjust aminoglycosides and vancomycin based on creatinine clearance. --- 👀 Patterns to Recognize Gram‑positive cocci → cell‑wall synthesis inhibitors work well (e.g., penicillins). Gram‑negative rods with efflux pumps → look for resistance to tetracyclines, fluoroquinolones. Diarrhea after antibiotics → suspect C. difficile if watery, foul‑smelling, and recent broad‑spectrum use. Rapid clinical deterioration despite bacteriostatic therapy → consider switching to bactericidal agent. --- 🗂️ Exam Traps “All broad‑spectrum antibiotics are better.” – Overuse drives resistance; narrow‑spectrum is preferred when pathogen known. “MIC = therapeutic dose.” – MIC is an in‑vitro value; clinical dosing also accounts for PK, site penetration, and patient factors. “Prophylactic antibiotics have no side effects.” – They still disrupt flora, can cause C. diff, and promote resistance. “All β‑lactam antibiotics are interchangeable.” – Spectrum, stability against β‑lactamases, and pharmacokinetics differ. “Synergy always occurs with combination therapy.” – Some combos are antagonistic (e.g., chloramphenicol + penicillin). ---